Walking through the forest of transgenic models of human disease

Immunological Reviews

Volumn 169, Issue , 1999, Pages 5-10

  Eynon, Elizabeth E ^a   Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; APOPTOSIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; DENDRITIC CELL; DIABETES MELLITUS; DISEASE MODEL; GENE EXPRESSION; IMMUNOSTIMULATION; KNOCKOUT MOUSE; LUPUS ERYTHEMATOSUS; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TRANSGENE; TREATMENT PLANNING; ULCERATIVE COLITIS;

ANIMALS; APOPTOSIS; ARTHRITIS, RHEUMATOID; COLITIS, ULCERATIVE; DENDRITIC CELLS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 0032795777     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01301.x     Document Type: Review

References (10)

1. 1. Lo D, et al. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic β cells. Cell 1988;53:159-168.
2. 2. Schorle H, Holtschke T, Hunig T, Schimpel A, Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991;352:621-624.
3. 3. MacDonald TT. Inflammatory bowel disease in knockout mice. Curr Biol 1994;4:261-263.
4. 4. Furth P, et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994;91:9302-9306.
5. 5. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992;89:5547-5551.
6. 6. Kistner A, et al. Deoxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996;93:10933-10938.
7. 7. Sauer B. Site-specific recombination: developments and applications. Curr Opin Biotechnol 1994;5:521-527.
8. 8. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996;87:811-822.
9. 9. Fisher A, et al. Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol 1997;15:93-124.
10. 10. Klein J. Natural history of the major histocompatibility complex. New York; John Wiley and Sons; 1986. p. 425-441.